<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study, 32 patients under the age of 17 years with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AAA) were evaluated </plain></SENT>
<SENT sid="1" pm="."><plain>Nine patients developed AAA associatedwith <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in which <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> and <z:e sem="disease" ids="C0008049" disease_type="Disease or Syndrome" abbrv="">varicella infection</z:e> were nearly equal </plain></SENT>
<SENT sid="2" pm="."><plain>Four of the patients were administered drugs before developing AAA </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were treated as follows: combined immunosuppressive therapy (CIST) including anti-thymocyte or anti-lymphocyte globulin plus high-dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> (HDMP) and <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> and granulocyte colony-stimulating factor (G-CSF) (14 patients); mega-dose (30 mg/kg) <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> (8 patients); and HDMP combined with <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> or anapolon or <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (6 patients) </plain></SENT>
<SENT sid="4" pm="."><plain>Complete remission was seen in 10 patients and partial remission in 2 patients </plain></SENT>
<SENT sid="5" pm="."><plain>The response rate was similar in the CIST and MDMP groups </plain></SENT>
<SENT sid="6" pm="."><plain>The most striking findings of this study were the frequent association of AAA withvaricella <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and the low cure rate, which was due to patient non-compliance with the treatment and inadequate isolation conditions in the hospital </plain></SENT>
</text></document>